1) normal endometrium
正位内膜
2) Eutopic endometrium
在位内膜
1.
Effects of progestin and/or GnRHa on mRNA expression of VEGFs in eutopic endometrium with endometriosis;
体内外孕激素和GnRHa对子宫内膜异位症患者在位内膜血管内皮生长因子表达影响的差异
2.
Specific expression and significance of endocrine gland-derived vascular endothelial growth factor in both eutopic endometrium and the nude mice model of endometriosis;
内分泌腺体来源的血管内皮生长因子在子宫内膜异位症在位内膜及裸鼠模型中的特异性表达及意义
3.
Objective To investigate the apoptosis-related mechanisms of levenorgestrel-releasing intrauterine system(LNG-IUS),oral medroxyprogesterone(MPA),and injective gonadotrophic hormone releasing hormone agonist(GnRHa)on eutopic endometrium of patients with endometriosis.
目的探讨药物治疗,包括左炔诺孕酮宫内节育系统(LNG-IUS)、口服甲羟孕酮(MPA)或注射促性腺激素释放激素类似物(GnRHa)对子宫内膜异位症患者在位内膜凋亡的的影响。
3) Ectopic endometrium
异位内膜
1.
Effect of danazol on rat ectopic endometrium;
丹那唑对子宫内膜异位症大鼠异位内膜的影响
2.
Objectives: To study the expression and steroidal regulation of integrinα_5 and integrinβ_3 in eutopic endometrium and ectopic endometrium ,and to investigate the effects of estradiol、progesterone、anti- estradiol and anti-progesterone on the expression of integrinα_5、β_3mRNA in cultured human endometriotic cells in vitro.
目的:探讨整合素在子宫内膜异位症在位内膜和异位内膜中的表达及其性激素依赖性,并研究雌激素、孕激素、抗雌激素制剂、抗孕激素制剂对体外培养的人异位子宫内膜细胞整合素α_5、β3mRNA表达的影响,寻求整合素在子宫内膜异位症发生发展过程中的作用,为临床诊断和治疗该疾病做进一步努力。
3.
Objective: To investigate the expression of the tissue inhibitor of metalloproteinase-2 in the eutopic and ectopic endometrium from women with and without endometriosis, there by to determine the role of the tissue inhibitor of metalloproteinase-2 (TIMP-2) in the pathogenesis of endometriosis.
TIMP-2mRNA在子宫内膜异位症异位内膜和在位内膜组织中均低表达,其相对表达量分别为(0。
4) Eutopic endometrium
异位内膜
1.
Objective To study the expression patterns of ER and P450arom in the ectopic and eutopic endometrium with adenomyosis and the normal endometrium without estrogen-dependent disorders.
结果 ① 在腺肌病患者的在位和异位内膜、正常子宫内膜中均检测到了ER和P450arom的表达:② 在各组内,腺上皮细胞和间质细胞相比,ER和P450arom表达无差异(P>0。
5) ectopic implants
异位内膜
1.
Methods The stromal cell of ectopic implants was exposed to various concentrations (5、10、20μg/L )of IL-1β and the 10μg/L of IL-1β was cocultured with ectopic implants, eutopic and normal endometrium.
方法对2006年9月至2007年6月南京医科大学第一附属医院收治的11例EMS患者的异位、在位内膜基质细胞和同期5例正常内膜基质细胞行分离培养,分别加入5、10、20μg/L的IL-1β刺激培养异位内膜基质细胞,选择最佳浓度的IL-1β刺激培养异位、在位和正常内膜基质细胞,采用RT-PCR及ELISA法从转录及转录后水平观察趋化因子RANTES表达模式的变化情况。
2.
Methods:The stromal cell of ectopic implants was exposed to various concentrations(5,10,20 ng/ml) of IL-1β and the 10 ng/ml of IL-1β was cocultured with ectopic implants,eutopic and normal endometrium.
目的:比较子宫内膜异位症患者异位内膜、在位内膜和正常子宫内膜分泌RANTES的水平,以了解盆腔局部趋化巨噬细胞浸润的始动因素。
6) inner unit memebrane
内单位膜
补充资料：阔韧带子宫内膜异位症
阔韧带子宫内膜异位症
病名。指子宫内 膜异位于阔韧带处者。为子宫内膜异位症类型之一。是盆腔子宫内膜异位的一部分。多发生 于阔韧带底部结缔组织中。临床表现为经前2～3天开始出现下腹痛，月经后疼痛缓解。如果 累及骶丛神经，可引起坐骨神经痛。病理检查可在病变部位找到子宫内膜组织。详参子宫内 膜异位症条。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条